tirzepatide compound ending The End of Compounded Tirzepatide: What You Need to Know led and built for women A Major GLP-1 Drug Shortage

Open 7, e2428280

This glucagon-like peptide-1 (GLP-1) receptor agonist, through its multifaceted action, not only improves glycemic control but also facilitates weight reduction, thus addressing two critical components of metabolic syndrome

The 2026 Standards of Care by the American Diabetes Association (ADA) recommend them for adults with type 2 diabetes who also have obesity or overweight, atherosclerotic cardiovascular disease, heart failure, chronic kidney disease or metabolic-associated steatotic liver disease [4]

However, remember that sustainable weight loss is a holistic endeavor encompassing lifestyle changes, not solely medication